文献速递神经肿瘤

五特征模型预测低级别胶质瘤患者生存

Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
PubMed 文献 · World Neurosurg · 2019-03-07

该研究基于TCGA数据集的低级别胶质瘤miRNA表达谱与临床信息,用随机森林及Cox回归筛选出2个miRNA和3个临床因素构建5特征模型,将患者分为高风险与低风险组,并在测试与验证数据集中验证其生存预测价值。

要点

  • 基于TCGA低级别胶质瘤数据构建了含2个miRNA和3个临床因素的5特征生存预测模型。
  • 5特征模型将训练集患者分为高风险与低风险组,ROC曲线显示其具有竞争性预测性能。
  • 该模型的预后价值在测试集与验证集中得到成功验证。

核心结论

  • 该研究显示新型5特征模型作为低级别胶质瘤患者生存预测的独立生物标志物具有良好潜力。

研究设计与样本

  • 研究从TCGA数据集获取低级别胶质瘤患者的miRNA表达谱与临床信息。
  • 对591个miRNA使用随机森林生存、回归与分类方法建模并进行特征选择。
  • 采用单因素和多因素Cox回归分析筛选与总生存相关的差异表达miRNA及临床因素。

主要发现

  • 在低级别胶质瘤与正常组织间共获得591个差异表达miRNA。
  • 经单因素和多因素Cox回归分析最终筛选出2个预测性miRNA(hsa-miR-10b-5p和hsa-miR-15b-5p)和3个临床因素(分级、年龄和癌症状态)构建5特征模型。
  • 基于5特征模型将训练数据集患者分为高风险组和低风险组。
  • ROC曲线分析显示5特征模型具有竞争性预测性能。
  • 5特征模型的预后价值在测试数据集和验证数据集中得到成功验证。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the study, we aimed to identify key microRNAs (miRNAs) and clinical factors associated with survival time of lower-grade glioma (LGG) and develop an expression-based miRNA signature to provide survival risk prediction for patients with LGG. METHODS: We obtained miRNA expression profiles and clinical information of patients with LGG from The Cancer Genome Atlas dataset. All 591 miRNAs were modeled using random Forest Survival, Regression, and Classification to construct a random forest model for survival analysis, and feature selection was performed. We used univariate and multivariate Cox regression analysis to screen differentially expressed miRNAs and clinical factors related to overall survival of patients with LGG. RESULTS: A total of 591 differentially expressed miRNAs were obtained between LGG and normal tissues. After univariate and multivariate Cox regression analysis, 2 predictive miRNAs (hsa-miR-10b-5p and hsa-miR-15b-5p) and 3 clinical factors (grade, age, and cancer status) were finally screened out to construct a 5-signature, based on which patients in the training dataset were divided into high-risk and low-risk groups. The competitive performance of the 5-signature was revealed by receiver operating characteristic curve analysis. The prognostic value of the 5-signature was successfully validated in the testing and validation dataset. CONCLUSIONS: Our study demonstrated the promising potential of the novel 5-signature as an independent biomarker for survival prediction of patients with LGG.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Xiao H, Bai J, Yan M, et al. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma. World Neurosurg. 2019. PMID: 30853516. doi:10.1016/j.wneu.2019.02.147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。